ES2450865B2 - Nanocajas catalíticas, usos y procedimiento de síntesis - Google Patents

Nanocajas catalíticas, usos y procedimiento de síntesis Download PDF

Info

Publication number
ES2450865B2
ES2450865B2 ES201331906A ES201331906A ES2450865B2 ES 2450865 B2 ES2450865 B2 ES 2450865B2 ES 201331906 A ES201331906 A ES 201331906A ES 201331906 A ES201331906 A ES 201331906A ES 2450865 B2 ES2450865 B2 ES 2450865B2
Authority
ES
Spain
Prior art keywords
catalytic
sup
metal
nanocajas
synthesis procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES201331906A
Other languages
English (en)
Other versions
ES2450865A1 (es
Inventor
Marcelino MANEIRO MANEIRO
Gustavo GONZÁLEZ RIOPEDRE
María Isabel FERNÁNDEZ GARCÍA
Ana María GONZÁLEZ NOYA
Manuel Rafael BERMEJO PATIÑO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universidade de Santiago de Compostela
Original Assignee
Universidade de Santiago de Compostela
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidade de Santiago de Compostela filed Critical Universidade de Santiago de Compostela
Priority to ES201331906A priority Critical patent/ES2450865B2/es
Publication of ES2450865A1 publication Critical patent/ES2450865A1/es
Application granted granted Critical
Publication of ES2450865B2 publication Critical patent/ES2450865B2/es
Priority to PCT/ES2014/070821 priority patent/WO2015097325A1/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/1691Coordination polymers, e.g. metal-organic frameworks [MOF]
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/18Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms
    • B01J31/1805Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms the ligands containing nitrogen
    • B01J31/181Cyclic ligands, including e.g. non-condensed polycyclic ligands, comprising at least one complexing nitrogen atom as ring member, e.g. pyridine
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82BNANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
    • B82B1/00Nanostructures formed by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00Nanotechnology for materials or surface science, e.g. nanocomposites
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/70Complexes comprising metals of Group VII (VIIB) as the central metal
    • B01J2531/72Manganese

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nanotechnology (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Composite Materials (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • General Physics & Mathematics (AREA)
  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Nanocajas catalíticas, usos y procedimiento de síntesis. La presente invención comprende una nueva familia de complejos metalo-orgánicos cuya estructura supramolecular forma una caja cuyo tamaño se puede modular en función de la composición del complejo y que puede presentar propiedades catalíticas. Los complejos de la invención presentan la formulación general [M{sup,1}(L) M{sup,2}D){sub,x}]{sub,n}. Siendo M{sup,1} el primer metal o centro metálico, M{sup,2} un segundo metal, D un disolvente y L un ligando tetradentado.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
P201331906
23-12-2013
Caracterización: Sólido color blanco, punto fusión 180 ºC Análisiselemental [Experimental (teórico)]: %C, 64.0 (64.0); %H, 5.5 (5.4); %N, 9.4(9.3) Infrarrojo: Una banda fuerte y estrecha a 3377 y 3408 cm-1, correspondiente a la vibración de tensión ν (N-H);
5 Una banda a 3076 cm-1, que corresponde a la vibración de tensión del grupo (O-H);amido I: a 1645 cm-1, correspondiente a la vibración de tensión del carbonilo de la amida; amido II: aparece entre 1549 cm-1, es una banda de combinación de la vibración de deformación o flexión del N-H y de la vibración del enlace C-N (Figura 1).
Espectrometría de masas (ESI): ión molecular 301 (L+1)+, (ver Figura 2). Espectrometría RMN 1H: señalprotónamínico a 8,95 (s, 2H); aromáticos a 6,85 7,36 7,80 (t, 4H) (t, 2H) (d, 2H); señalprótonesmetilénicos 2,48 (d, 2H); ver Figuras 3 y 4. 10 RMN de 13C (ver Figura 5):
Ligando
C-OH(a) C=O(G) (-CH2-)(H) δ(-CH2-)(l)
H4L
161,1 169,9 39,4 -
15 Difracción de Rayos X: Datos recogidos a 293 K en un difractómetroSmart-CCD-1000 BRUKER' (ánodo rotante) (ver Figura 6).
Fórmula Empirica
C16H16N2O4
Peso Molecular
300,31
Temperatura
293 (2) K
Longitud de Onda
0,71073 Å
Sistema Cristalino
Triclínico
Grupo Espacial
P–1
Dimensiones de la celda unidad
a = 6,545(3) Ǻ; b = 6,964(3) Ǻ; c = 15,297(8) Ǻ α = 94,318(8)º; β = 94,205(10)°; γ = 95,464(16)º
Volumen
689,9(6) Ǻ3
Z
2
Densidad (calculada)
1,446 Mg/m3
Coeficiente de absorción
0,105 mm-1
F(000)
316
Reflexiones recogidas
2589
imagen6
imagen7
imagen8
imagen9
P201331906
23-12-2013 P201331906
Coeficiente de absorción
0,950 mm-1
F(000)
464
Amplitud de barrido
2,10 a 23,25°
Reflexiones recogidas
6105
Reflexiones independientes
2579 [R(int) = 0,1210]
Índices R finales
R1 = 0,0876, wR2 = 0,1949
Índices R (todos los datos)
R1 = 0,1446, wR2 = 0,2258
Distancias de enlace (Å)
Mn(1)-O(1)
1,864(5) Mn(1)-O(2) 1,879(6)
Mn(1)-N(1)
1,921(7) Mn(1)-N(2) 1,925(6)
Mn(1)-O(5)
2,213(7) Mn(1)-K(1) 3,784(3)
Mn(1)-K(1)#1
4,111(3) O(2)-K(1)#1 3,003(6)
O(1)-K(1)
2,821(6) O(3)-K(1)#2 2,693(7)
O(2)-K(1)
2,864(6) O(4)-K(1)#3 2,793(6)
K(1)-O(3)#2
2,693(7) O(5)-K(1)#1 3,101(7)
K(1)-O(6B)
2,860(3) K(1)-O(4)#4 2,793(6)
K(1)-O(2)#1
3,003(6) K(1)-O(5)#1 3,101(7)
K(1)-K(1)#1
4,472(5) K(1)-Mn(1)#1 4,111(3)
Ángulos de enlace (º)
O(1)-Mn(1)-O(2)
90,8(2) K(1)-Mn(1)-K(1)#1 68,86(6)
O(2)-Mn(1)-N(1)
141,4(3) O(1)-Mn(1)-N(1) 92,4(3)
O(2)-Mn(1)-N(2)
91,9(3) O(1)-Mn(1)-N(2) 170,8(3)
O(1)-Mn(1)-O(5)
93,1(3) N(1)-Mn(1)-N(2) 83,8(3)
N(1)-Mn(1)-O(5)
97,4(3) O(2)-Mn(1)-O(5) 90,3(3)
O(1)-Mn(1)-K(1)
45,81(19) N(2)-Mn(1)-O(5) 95,7(3)
N(1)-Mn(1)-K(1)
133,0(2) O(2)-Mn(1)-K(1) 47,30(17)
O(5)-Mn(1)-K(1)
104,05(17) N(2)-Mn(1)-K(1) 133,6(3)
O(2)-Mn(1)-K(1)#1
42,4(2) O(1)-Mn(1)-K(1)#1 90,95(18)
N(2)-Mn(1)-K(1)#1
97,0(2) N(1)-Mn(1)-K(1)#1 145,4(3)
O(5)-Mn(1)-K(1)#1
47,98(18)
23-12-2013
Estructura [Mn(L)Rb(H2O)4]2: Ver Figuras 12, 13 y 14.
Estructura de la caja supramolecular: Rb(1A)-O3A27 = 2,928 Å; Rb(1A)-O24B = 3,201 Å; Rb(1B)-O24A = 2,893 Å; Rb(1B)-O(26W) = 3,100 Å.
Fórmula Empírica
C33 H36 Mn2 N4 O13 Rb2
Peso Molecular
977,48
Temperatura
120(2) K
Longitud de onda
0,71073 Å
Sistema Cristalino
Monoclínico
Grupo Espacial
P 21
Dimensiones de la celda unidad
a=9,6398(15) Å α=90º b=17,688(3) Å β=102,232(3)° c=10,5316(17) Å γ=90º
Volumen
1754,9(5) Å3
Z
2
Densidad (calculada)
1,850 Mg/m3
Coeficiente de absorción
3,549 mm-1
F(000)
980
Amplitud de barrido
1,97 ≥ 2θ 27,48°
Reflexiones recogidas
7897
Reflexiones independientes
6683 [R(int) = 0,0494]
Índices R finales
R1 = 0,0329, wR2 = 0,0695
Índices R (todos los datos)
R1 = 0,0443, wR2 = 0,0750
P201331906
23-12-2013 P201331906
Distancias de enlace (Å)
Mn(2A)-N(12A)
1,939(3) Mn(2B)-N(12B) 1,925(3)
Mn(2A)-N(15A)
1,960(3) Mn(2B)-N(15B) 1,942(3)
Mn(2A)-O(24A)
1,894(3) Mn(2B)-O(24B) 1,883(3)
Mn(2A)-O(3A)
1,874(3) Mn(2B)-O(3B) 1,863(3)
Mn(2A)-O(26W)
2,175(3) Mn(2B)-O(27) 2,212(3)
Mn(2A)-Rb(1A )
3,889 Mn(2B)-Rb(1B) 3,836
Mn(2A)-Rb(1B)
4,2735(9) Mn(2B)-Rb(1A) 4,344
Rb(1A)-O(3A)
2,928(3) Mn(2A)-Mn(2B) 6,677
O(17A)Rb(1A)#3
2,906(3) Rb(1B)-O(11A)#4 2,864(3)
O(24A)-Rb(1B)
3,243(3) Rb(1B)-O(25B) 3,431(3)
Rb(1A)-O(24A)
2,893(3) O(11A)-Rb(1B)#1 2,864(3)
Rb(1A)O(11B)#1
2,837(3) Rb(1B)-O(17B)#3 2,941(3)
Rb(1A)O(17A)#2
2,906(3) Rb(1B)-O(3B) 2,898(3)
Rb(1A)-O(24B)
3,201(3) Rb(1B)-O(24B) 2,881(3)
Rb(1A)-O(25A)
3,552(3) Rb(1B)O(29W)#5 3,004(4)
Rb(1A)-O(27)
3,189(3) Rb(1B)-O(26W) 3,100(3)
Rb(1A)-Rb(1B)
4,731
23-12-2013
Ángulos de enlace (˚)
O(3A)-Mn(2A)-O(24A)
89,67(12) O(24A)-Mn(2A)-Rb(1A) 45,42(9)
O(3A)-Mn(2A)-N(12A)
92,69(13) N(12A)-Mn(2A)-Rb(1A) 134,54(10)
O(24A)-Mn(2A)-N(12A)
172,67(15) N(15A)-Mn(2A)-Rb(1A) 130,16(10)
O(3A)-Mn(2A)-N(15A)
167,00(13) O(26W)-Mn(2A)-Rb(1A) 104,58(9)
O(24A)-Mn(2A)-N(15A)
91,55(13) O(3A)-Mn(2A)-Rb(1B) 91,81(9)
N(12A)-Mn(2A)-N(15A)
84,61(14) O(24A)-Mn(2A)-Rb(1B) 45,56(9)
O(3A)-Mn(2A)-O(26W)
95,78(12) N(12A)-Mn(2A)-Rb(1B) 141,18(11)
O(24A)-Mn(2A)-O(26W)
89,43(13) N(15A)-Mn(2A)-Rb(1B) 98,27(9)
N(12A)-Mn(2A)-O(26W)
97,23(14) O(26W)-Mn(2A)-Rb(1B) 43,95(9)
N(15A)-Mn(2A)-O(26W)
97,18(13) Rb(1A)-Mn(2A)-Rb(1B) 70,665(13)
O(3B)-Mn(2B)-N(12B)
92,76(13) O(24B)-Mn(2B)-N(12B) 175,20(14)
O(3B)-Mn(2B)-N(15B)
167,09(14) O(24B)-Mn(2B)-N(15B) 92,25(13)
N(12B)-Mn(2B)-N(15B)
84,09(14) O(3B)-Mn(2B)-O(27) 94,13(12)
O(24B)-Mn(2B)-O(27)
86,90(12) N(12B)-Mn(2B)-O(27) 96,70(14)
N(15B)-Mn(2B)-O(27)
98,67(13) O(3B)-Mn(2B)-Rb(1B) 46,78(9)
O(24B)-Mn(2B)-Rb(1B)
46,41(9) N(12B)-Mn(2B)-Rb(1B) 134,93(10)
N(15B)-Mn(2B)-Rb(1B)
130,20(11) O(27)-Mn(2B)-Rb(1B) 104,02(8)
O(3B)-Mn(2B)-Rb(1A)
91,97(8) O(24B)-Mn(2B)-Rb(1A) 41,94(9)
N(12B)-Mn(2B)-Rb(1A)
141,64(11) N(15B)-Mn(2B)-Rb(1A) 98,28(10)
O(27)-Mn(2B)-Rb(1A)
44,98(8) Rb(1B)-Mn(2B)-Rb(1A) 70,355(13)
O(3A)-Mn(2A)-Rb(1A)
46,35(9) O(3B)-Mn(2B)-O(24B) 90,14(12)
Estructura [Mn(L)Cs(H2O)]2: Ver Figura 15 y 16.
Estructura caja supramolecular: Cs1-O3 ….3,137 Å; Cs1-O131…3,107 Å; Cs1-O111…3,167 Å; Mn(2)-Cs(1) 4,142 Å; Mn(2)-Cs(1)#1...4,1417 Å; Cs…Cs ….4,870 Å .
P201331906
23-12-2013
Fórmula Empírica
C32H28N4O10Cs2Mn2
Peso Molecular
1004.28
Temperatura
120(2)K
Longitud de onda
0,71073 Å
Sistema Cristalino
Monoclínico
Grupo Espacial
P 21/c
a=10,839(2) Å
Dimensiones de la celda unidad
b=15,437(3) Å =92,052(4)°
c=9,3724(19) Å
Volumen
1567,2(5) Å3
Z
4
Densidad (calculada)
2,128 Mg/m3
Coeficiente de absorción
3,163 mm-1
F(000)
976
Amplitud de barrido
1,88 ≥ 2θ 27,88º
Reflexiones recogidas
28977
Reflexiones independientes
3736 [R(int) = 0,088]
Índices R finales
R1 = 0,0374, wR2 = 0,0699
Índices R (todos los datos)
R1 = 0,0618, wR2 = 0,0749
imagen10
imagen11
P201331906
23-12-2013
Tabla 1. Actividad Catalasa de los complejos
Complejo
Metanol Dimetilformamida
23·C
36 ·C 23·C 36 ·C
[MnLNa(H2O]2
Ciclos catalíticos % actividad 118 ± 6 18 ± 3 336 ± 3 51 ± 4 226 ± 5 34 ± 3 364 ± 8 55 ± 4
[Mn(L)K(CH3OH)(H2O)]2
Ciclos catalíticos % actividad 667± 1 100± 2 667± 1 100± 2 216± 8 33 ± 4 667± 1 100± 2
[Mn(L)Rb(H2O)4]2
Ciclos catalíticos % actividad 162 ± 6 25 ± 3 368± 22 55 ± 7 178± 12 28 ± 6 316± 6 47 ± 3
[Mn(L)Cs(H2O)]2
Ciclos catalíticos % actividad 110 ± 5 17 ± 3 384 ± 8 58 ± 4 80 ± 5 13 ± 3 166 ± 7 27 ± 4
Mn(3-OCH3salen)(Cl)(H2O)
Ciclos catalíticos % actividad 18 ± 2 38 ± 4

Claims (1)

  1. imagen1
    imagen2
ES201331906A 2013-12-23 2013-12-23 Nanocajas catalíticas, usos y procedimiento de síntesis Active ES2450865B2 (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ES201331906A ES2450865B2 (es) 2013-12-23 2013-12-23 Nanocajas catalíticas, usos y procedimiento de síntesis
PCT/ES2014/070821 WO2015097325A1 (es) 2013-12-23 2014-11-04 Nanocajas catalíticas, usos y procedimiento de síntesis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201331906A ES2450865B2 (es) 2013-12-23 2013-12-23 Nanocajas catalíticas, usos y procedimiento de síntesis

Publications (2)

Publication Number Publication Date
ES2450865A1 ES2450865A1 (es) 2014-03-25
ES2450865B2 true ES2450865B2 (es) 2014-10-29

Family

ID=50290379

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201331906A Active ES2450865B2 (es) 2013-12-23 2013-12-23 Nanocajas catalíticas, usos y procedimiento de síntesis

Country Status (2)

Country Link
ES (1) ES2450865B2 (es)
WO (1) WO2015097325A1 (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19728021A1 (de) * 1997-07-01 1999-01-07 Clariant Gmbh Metall-Komplexe als Bleichaktivatoren

Also Published As

Publication number Publication date
WO2015097325A1 (es) 2015-07-02
ES2450865A1 (es) 2014-03-25

Similar Documents

Publication Publication Date Title
Dilworth et al. Metal complexes of thiosemicarbazones for imaging and therapy
Paudler et al. 1, 2, 4‐triazines. III. A convenient synthesis of 1, 2, 4‐triazines and their covalent hydration
ES2454966T3 (es) Compuestos para la prevención y el tratamiento de enfermedades cardiovasculares
Thakuria et al. 7.03-Hydrogen bonding in molecular crystals
ES3050217T3 (en) Tricyclic parp1 inhibitors and uses thereof
Zapała et al. Synthesis, spectral and thermal study of La (III), Nd (III), Sm (III), Eu (III), Gd (III) and Tb (III) complexes with mefenamic acid
Nikitina et al. Synthesis and study of prototropic tautomerism of 2-(2-hydroxyphenyl)-1-hydroxyimidazoles
Nasr et al. Carbonic anhydrase inhibitors. Inhibition of human cytosolic isoforms I and II with (reduced) Schiff’s bases incorporating sulfonamide, carboxylate and carboxymethyl moieties
ES2450865B2 (es) Nanocajas catalíticas, usos y procedimiento de síntesis
Lihumis et al. Synthesis and diagnosis of triazole and oxirane derivatives from hydroxyquioline with evaluating their biological and antioxidant activity
Ala'a et al. A catecholamine neurotransmitter: epinephrine as a CO 2 wet scrubbing agent
Jaafar et al. Synthesis, characterization and corrosion inhibition study of new heterocyclic compounds and schiff base with [Co (II), Ni (II), Cu (II) and Hg (II)] complexes
Alsenani Design, synthesis and antitumor activity of new naproxen based 1, 2, 4-triazole-Schiff base derivatives
Cao et al. Ferrocene-based anion receptor bearing amide and triazolium donor groups
Tarai et al. Quaternary and senary sub-assemblies in cocrystals and salts of quinoline-4-carbaldoxime with aromatic carboxylic acids
Shakir et al. Hybrid pharmacophore approach for bio-relevant di-imines based homobimetallic complexes incorporating functionalized dicarboxylates as co-ligands: Synthesis, spectral and structural activity dependent biological insights (in-vitro DNA and HSA binding, antioxidant and cytotoxicity)
Ni et al. Novel imidazolium chiral ionic liquids that contain a urea functionality
Prasanna Kumar et al. Synthesis and in vitro antiproliferative activity of 2, 5-disubstituted-1, 3, 4-oxadiazoles containing trifluoromethyl benzenesulfonamide moiety
Kumar et al. Facile syntheses of novel salts of a triazole antifungal agent with enhanced solubility
Saiprathima et al. “On water” one-pot synthesis of quaternary centered 3-hydroxy-3-(1 H-tetrazol-5-yl) indolin-2-ones
Nawaf I Design, synthesis and antitumor activity of new naproxen based 1, 2, 4-triazole-Schiff base derivatives
SHARMA et al. Ionic liquid mediated synthesis, reactions, and insecticidal activity of 1-[(1H-benzoimidazol-2-yl) amino] spiro [azetidine-4, 4'-[4'H] chroman]-2-ones
kareem Hussien et al. Development of Thiadiazole and Schiff Base Derivatives: Synthesis, Spectral Characterization, and Antibacterial Activity Assessment
Kaiser et al. CHEMISTRY OF DICYANDIAMIDE. III. REACTION OF ACYLDICYANDIAMIDES WITH HYDRAZINE
JP2015131783A (ja) アリール−1,2,4−トリアゾール誘導体の製造方法

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 2450865

Country of ref document: ES

Kind code of ref document: B2

Effective date: 20141029